Related Experiment Videos
Myocardial dysfunction in rheumatoid arthritis: epidemiology and pathogenesis
Jon T Giles1, Verônica Fernandes, Joao A C Lima
1Division of Rheumatology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA. gilesjont@jhmi.edu
Arthritis Research & Therapy
|October 7, 2005
Summary
Rheumatoid arthritis patients face increased risk of congestive heart failure, potentially driven by inflammatory cytokines. Further research is needed to understand these effects on the heart.
Area of Science:
- Cardiovascular Medicine
- Rheumatology
- Immunology
Background:
- Rheumatoid arthritis (RA) patients exhibit a higher incidence of congestive heart failure (CHF).
- Established CHF risk factors are prevalent in RA patients, contributing to this elevated risk.
- Inflammatory cytokines, abundant in RA synovium, are implicated in myocardial dysfunction in animal models.
Purpose of the Study:
- To investigate the direct impact of inflammatory cytokines and RA therapies on the myocardium of RA patients.
- To elucidate the mechanisms linking RA-associated inflammation to heart failure.
Main Methods:
- Review of epidemiologic studies and animal models.
- Analysis of data linking rheumatoid arthritis, inflammatory cytokines, and congestive heart failure.
Main Results:
- Epidemiologic data indicate a significant risk of CHF in RA patients.
- Animal studies suggest inflammatory cytokines produced in RA are key drivers of myocardial maladaptation.
- The direct effects of these cytokines and RA treatments on the RA patient myocardium remain unclear.
Conclusions:
- Inflammatory processes in rheumatoid arthritis likely contribute to the development of congestive heart failure.
- Further investigation is crucial to understand the direct myocardial effects of cytokines and RA therapies in patients.
- Targeting inflammatory pathways may offer a strategy for preventing heart failure in RA.